2022
DOI: 10.1101/2022.04.18.22273967
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses

Abstract: SUMMARYDue to the recrudescence of SARS-CoV-2 infections worldwide, mainly caused by Omicron BA.1 and BA.2 variants of concern, several jurisdictions are administering a mRNA vaccine boost. Here, we analyzed humoral responses induced after the second and third doses of mRNA vaccine in naïve and previously-infected donors who received their second dose with an extended 16-week interval. We observed that the extended interval elicited robust humoral responses against VOCs, but this response was significantly dim… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
22
1

Year Published

2022
2022
2022
2022

Publication Types

Select...
4
1

Relationship

4
1

Authors

Journals

citations
Cited by 5 publications
(28 citation statements)
references
References 44 publications
5
22
1
Order By: Relevance
“…We analyzed humoral immune responses in cohorts of 31 kidney, 11 liver, 14 lung and 8 heart organ transplant recipients after the second (median shown that this extended interval regimen leads to strong humoral and cellular responses after the second dose, notably against VOCs (Chatterjee et al, 2022;Nayrac et al, 2021;Payne et al, 2021;Tauzin et al, 2022a). This allowed us to compare humoral responses obtained in SOTR versus humoral responses elicited by a long interval vaccination regimen.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…We analyzed humoral immune responses in cohorts of 31 kidney, 11 liver, 14 lung and 8 heart organ transplant recipients after the second (median shown that this extended interval regimen leads to strong humoral and cellular responses after the second dose, notably against VOCs (Chatterjee et al, 2022;Nayrac et al, 2021;Payne et al, 2021;Tauzin et al, 2022a). This allowed us to compare humoral responses obtained in SOTR versus humoral responses elicited by a long interval vaccination regimen.…”
Section: Resultsmentioning
confidence: 99%
“…HCW received their first two doses of mRNA vaccine with a 16-week extended interval (median [range]: 111 days [76–134 days]), and their third dose around seven months after the second dose (median [range]: 219 days [167-235 days]), according to the province of Quebec, Canada public health authority’s vaccination roll out guidelines for HCW. Several studies have shown that this extended interval regimen leads to strong humoral and cellular responses after the second dose, notably against VOCs (Chatterjee et al, 2022; Nayrac et al, 2021; Payne et al, 2021; Tauzin et al, 2022a). This allowed us to compare humoral responses obtained in SOTR versus humoral responses elicited by a long interval vaccination regimen.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations